supply chain discussion

profileAngela gomez
15668.docx

Please start each discussion board posting with your name (Jane Doe). Your initial original post must be a minimum of 300 words and submitted by 11:30 pm on the indicated due date in the course calendar. Your responses to classmates' posts must be a minimum of 150 words each and be submitted by 11:30 pm on the indicated due date in the course calendar. Also, keep in mind the grading criteria included in the Grading Rubric. Your reply post must provide something new to the conversation rather than simply expressing agreement with the original author.

Assignment:

Read the two articles, one from Forbes and one from the Washington Post, found at the links below:

Fate Of Pharma’s Reputation Lies In Gilead’s Hands On Pricing Of Covid-19 Drug Remdesivir

Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price

The articles discuss some of the factors that Gilead must consider in pricing its Covid-19 treatment drug.

In your original post, form an opinion as to what price the company should set for a treatment course per patient. Keep in mind taxpayer support, stockholders and investor interests, employee interests, and the potential break-even point of the drug. Communicate your opinion along with evidence to back up and justify your cost.

Please start each discussion board posting with your name (Jane Doe). Your initial original post

must be

a minimum of 300 words and submitted by 11:30 pm on the indicated due date in the course calendar.

Your responses to classmates' posts must be a minimum of 150 words each and be submitted by 11:30

pm on the indicated due date in the course calendar

. Also, keep in mind the grading criteria included in

the Grading Rubric. Your reply post must provide something new to the conversation rather than simply

expressing agreement with the original author.

Assignment:

Read the two articles, one from Forbes

and one from the Washington Post, found at the links below:

Fate Of Pharma’s Reputation Lies In Gilead’s Hands On Pricing Of Covid

-

19 Drug Remdesivir

Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price

The articles discu

ss some of the factors that Gilead must consider in pricing its Covid

-

19 treatment drug.

In your original post, form an opinion as to what price the company should set for a treatment course

per patient. Keep in mind taxpayer support, stockholders and inv

estor interests, employee interests, and

the potential break

-

even point of the drug. Communicate your opinion along with evidence to back up

and justify your cost.

Please start each discussion board posting with your name (Jane Doe). Your initial original post must be

a minimum of 300 words and submitted by 11:30 pm on the indicated due date in the course calendar.

Your responses to classmates' posts must be a minimum of 150 words each and be submitted by 11:30

pm on the indicated due date in the course calendar. Also, keep in mind the grading criteria included in

the Grading Rubric. Your reply post must provide something new to the conversation rather than simply

expressing agreement with the original author.

Assignment:

Read the two articles, one from Forbes and one from the Washington Post, found at the links below:

Fate Of Pharma’s Reputation Lies In Gilead’s Hands On Pricing Of Covid-19 Drug Remdesivir

Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price

The articles discuss some of the factors that Gilead must consider in pricing its Covid-19 treatment drug.

In your original post, form an opinion as to what price the company should set for a treatment course

per patient. Keep in mind taxpayer support, stockholders and investor interests, employee interests, and

the potential break-even point of the drug. Communicate your opinion along with evidence to back up

and justify your cost.